The breast cancer drug tamoxifen kills the single-celled
parasite known as leishmania, a scourge common in the tropics, Brazilian
scientists report. While the tests in mice are preliminary, the finding is heartening
because few good treatments for leishmaniasis exist, says Silvia Uliana, a
physician at the University
of São Paulo.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.